HEPATOLOGY

HEPATOLOGY

HEPATOLOGY
影响因子:15.8
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:John Wiley and Sons Ltd
发刊时间:1981
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0270-9139

期刊介绍

The premier publication in the field of liver disease publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease.Each month, the distinguished editorial board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.
肝脏疾病领域的首要出版物发表原创的、同行评审的文章,涉及肝脏结构、功能和疾病的各个方面。每个月,杰出的编辑委员会都会监督并选择最好的文章,如免疫学、慢性肝炎、病毒性肝炎、肝硬化、遗传和代谢性肝病及其并发症、肝癌和药物代谢。
年发文量 320
国人发稿量 81.98
国人发文占比 0.26%
自引率 -
平均录取率0
平均审稿周期 平均1.0个月
版面费 US$2900
偏重研究方向 医学-胃肠肝病学
期刊官网 http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1527-3350/
投稿链接 http://mc.manuscriptcentral.com/hep

期刊高被引文献

A Noncoding Regulatory RNAs Network Driven by Circ‐CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma
来源期刊:HepatologyDOI:10.1002/hep.30795
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
来源期刊:HepatologyDOI:10.1002/hep.31065
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum
来源期刊:HepatologyDOI:10.1002/hep.30672
Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress.
来源期刊:HepatologyDOI:10.1002/hep.30652
National Experience on Down‐Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha‐Fetoprotein, and Wait Time
来源期刊:HepatologyDOI:10.1002/hep.30879
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant
来源期刊:HepatologyDOI:10.1002/hep.30799
Hippo Signaling Controls NLR Family Pyrin Domain Containing 3 Activation and Governs Immunoregulation of Mesenchymal Stem Cells in Mouse Liver Injury
来源期刊:HepatologyDOI:10.1002/hep.30700
The NACSTOP Trial: A Multicenter, Cluster‐Controlled Trial of Early Cessation of Acetylcysteine in Acetaminophen Overdose
来源期刊:HepatologyDOI:10.1002/hep.30224
An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017
来源期刊:HepatologyDOI:10.1002/hep.30833
p53 Up‐regulated Modulator of Apoptosis Induction Mediates Acetaminophen‐Induced Necrosis and Liver Injury in Mice
来源期刊:HepatologyDOI:10.1002/hep.30422
Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study
来源期刊:HepatologyDOI:10.1002/hep.30859
Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights
来源期刊:HepatologyDOI:10.1002/hep.30424
Liver Transplantation for Acute Liver Failure Due to Dengue Fever
来源期刊:HepatologyDOI:10.1002/hep.30803
Incretin‐Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
来源期刊:HepatologyDOI:10.1002/hep.30670
Methyl‐Sensing Nuclear Receptor Liver Receptor Homolog‐1 Regulates Mitochondrial Function in Mouse Hepatocytes
来源期刊:HepatologyDOI:10.1002/hep.30884
The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease
来源期刊:HepatologyDOI:10.1002/hep.30288
Targeting Transforming Growth Factor Beta Signaling in Liver Cancer
来源期刊:HepatologyDOI:10.1002/hep.30426
Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use
来源期刊:HepatologyDOI:10.1002/hep.30174
Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis
来源期刊:HepatologyDOI:10.1002/hep.30658
Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection
来源期刊:HepatologyDOI:10.1002/hep.31003
Glial Cell Line–Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity
来源期刊:HepatologyDOI:10.1002/hep.30541
Paracentesis‐Induced Circulatory Dysfunction With Modest‐Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute‐on‐Chronic Liver Failure
来源期刊:HepatologyDOI:10.1002/hep.31071
Letter to the Editor: Defining Acute on Chronic Liver Failure: More Elusive Than Ever
来源期刊:HepatologyDOI:10.1002/hep.30589
Neurological Monitoring in Acute Liver Failure
来源期刊:HepatologyDOI:10.1002/hep.30760
lncRNA PSTAR Promotes p53 Signaling by Inhibiting hnRNP K deSUMOylation and Suppresses Hepatocellular Carcinoma.
来源期刊:HepatologyDOI:10.1002/hep.30793
Letter to Editor: Prognostic Role of Ammonia in Patients With Cirrhosis
来源期刊:HepatologyDOI:10.1002/hep.30758
HCV in Women and Pregnancy
来源期刊:HepatologyDOI:10.1002/hep.30791
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level
来源期刊:HepatologyDOI:10.1002/hep.30788
Cirrhotic Cardiomyopathy in Children With Biliary Atresia: A New Objective Parameter to Predict Morbidity and Mortality on the Wait List—and Beyond!
来源期刊:HepatologyDOI:10.1002/hep.30419
Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?
来源期刊:HepatologyDOI:10.1002/hep.30345
Letter to the Editor: Establishing Reliable Pediatric Percentiles of Serum Liver Enzyme Concentrations Cannot Ignore the Employed Methodology
来源期刊:HepatologyDOI:10.1002/hep.30503
Letter to the Editor: Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis: Contrast‐Enhanced Ultrasound May Be a Choice
来源期刊:HepatologyDOI:10.1002/hep.30819
Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
来源期刊:HepatologyDOI:10.1002/hep.31080
Reply
来源期刊:HepatologyDOI:10.1002/hep.30639
Reply
来源期刊:HepatologyDOI:10.1002/hep.30536
Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
来源期刊:HepatologyDOI:10.1002/hep.30551
Reply:
来源期刊:HepatologyDOI:10.1002/hep.30796
Reply
来源期刊:HepatologyDOI:10.1002/hep.30545
Fatigue in Primary Biliary Cholangitis: No Place for Rituximab
来源期刊:HepatologyDOI:10.1002/hep.30906
Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials
来源期刊:HepatologyDOI:10.1002/hep.30895
Letter to the Editor: Hypotheses and Assumptions in Mendelian Randomization: Proceed With Caution
来源期刊:HepatologyDOI:10.1002/hep.30599
Letter to the Editor: Liver Transplantation for Acute Liver Failure Because of Dengue Fever: First Successful Reported Case Worldwide
来源期刊:HepatologyDOI:10.1002/hep.30869
Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease
来源期刊:HepatologyDOI:10.1002/hep.30992
Concerns regarding the AARC Study on Corticosteroid therapy for Autoimmune Hepatitis flare causing ACLF.
来源期刊:HepatologyDOI:10.1002/hep.30787
Spontaneous Clearance of Chronic Delta Hepatitis
来源期刊:HepatologyDOI:10.1002/hep.31073
Reply:
来源期刊:HepatologyDOI:10.1002/hep.30619
Reply
来源期刊:HepatologyDOI:10.1002/hep.30287
Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease
来源期刊:HepatologyDOI:10.1002/hep.30797
Reply to Authors:Need to Identify AIH-ACLF as a distinct Entity.
来源期刊:HepatologyDOI:10.1002/hep.30784
Reply
来源期刊:HepatologyDOI:10.1002/hep.30564

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
99.06%17.59%-6.67%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
GASTROENTEROLOGY & HEPATOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区
2023年12月升级版
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区
2022年12月旧的升级版
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区